sluit venster

Log in

Gebruikersnaam Wachtwoord Gebruikersnaam en/of wachtwoord vergeten? Gebruikersnaam en wachtwoord aanvragen

Zoek in de HOVON website

Studies (all)


Study name Status Echelon level Stage Age Updated Included patients Active sites
HOVON 126 MM Closed Limited site selection 1st line 03-05-2018 143 40
HOVON 115 Double UCBT Closed Level A - 03-05-2018 70 6
HOVON-associated CMV pp65 specific T-cells Open n/a - 0 - 75 18-10-2012 n/a n/a
HOVON 34 MDS / EORTC 06961 Closed n/a 1st line 10 - 60 19-08-2018 n/a n/a
HOVON 29 AML / SAKK 30/95 Closed n/a 1st line 15 - 60 03-05-2018 n/a n/a
HOVON 27 NHL 94 Closed n/a 1st line 15 - 65 03-05-2018 n/a n/a
HOVON 26 NHL Closed n/a 1st line 15 - 65 03-05-2018 486 72
HOVON 32 MDS / ELDERLY AML Closed n/a 1st line 15 - 75 19-08-2018 n/a n/a
HOVON 37 ALL Closed n/a 1st line 16 - 59 03-05-2018 243 12
HOVON 18 ALL Closed n/a 1st line 16 - 60 03-05-2018 193 19
HOVON 38 CML Closed n/a 1st line 16 - 65 03-05-2018 102 22
HOVON 59 AML / SAKK / OSHO Closed n/a 1st line 16 - 75 03-05-2018 22 5
HOVON 70 ALL Closed n/a 1st line 18 - 39 03-05-2018 54 20
HOVON 72 AML Closed n/a 2nd line 18 - 60 03-05-2018 2 1
HOVON 66 AML Closed n/a 1st line 18 - 60 03-05-2018 n/a n/a
HOVON 42 AML / SAKK Closed n/a 1st line 18 - 60 03-05-2018 1002 4
HOVON 42 A AML / SAKK Closed n/a 1st line 18 - 60 03-05-2018 514 24
HOVON 90 T-NHL (ACT-1) Closed n/a 1st line 18 - 60 years 03-05-2018 n/a n/a
HOVON 133 MCL (TRIANGLE) Open Level D - 18 - 65 22-06-2018 n/a 24
HOVON 132 AML / SAKK Closed Limited site selection 1st line 18 - 65 03-05-2018 909 52
HOVON 102 AML Closed Limited site selection 1st line 18 - 65 07-12-2018 862 45
HOVON 92 AML / SAKK Closed Limited site selection 1st line 18 - 65 19-10-2018 n/a n/a
HOVON 80 NHL Closed n/a 2nd line 18 - 65 03-05-2018 36 12
HOVON 78 CML Closed n/a 1st line 18 - 65 20-06-2018 110 30
HOVON 75 MCL Closed n/a 1st line 18 - 65 03-05-2018 132 16
HOVON 69 T-NHL Closed n/a 1st line 18 - 65 03-05-2018 20 19
HOVON 65 MM / GMMG HD4 Closed n/a 1st line 18 - 65 03-05-2018 828 75
HOVON 63 NHL Closed n/a 1st line 18 - 65 03-05-2018 40 31
HOVON 54 MM Closed n/a 1st line 18 - 65 20-06-2018 87 6
HOVON 51 CML Closed n/a 1st line 18 - 65 19-08-2018 164 16
HOVON 50 MM Closed n/a 1st line 18 - 65 03-05-2018 555 47
HOVON 45 MCL Closed n/a 1st line 18 - 65 19-10-2018 87 17
HOVON 44 NHL Closed n/a 2nd line 18 - 65 03-05-2018 232 24
HOVON 40 NHL Closed n/a 1st line 18 - 65 03-05-2018 93 21
HOVON 138 APL (APOLLO) Open Limited site selection 1st line 18 - 65 years 10-10-2018 n/a 8
HOVON 76 MM Closed n/a 1st line 18 - 66 19-10-2018 35 8
HOVON 35 NHL / EORTC 20963 Closed n/a 1st line 18 - 66 03-05-2018 n/a n/a
HOVON 149 AL Amyloidosis Closed n/a - 18 - 70 03-05-2018 n/a n/a
HOVON 148 AML Open Level A - 18 - 70 31-07-2018 2 2
HOVON 146 ALL Open Level A, Level B 1st line 18 - 70 22-11-2018 4 4
HOVON 116 AML Closed Level A 1st line 18 - 70 03-05-2018 140 7
HOVON 105 PCNSL / ALLG NHL24 Closed Level C-HIC 1st line 18 - 70 11-12-2018 200 28
HOVON 100 ALL / EORTC Closed Level C-SCT 3rd line 18 - 70 20-11-2018 373 30
HOVON 96 GVHD Closed n/a 1st line 18 - 70 09-11-2018 494 7
HOVON 88 CLL Closed n/a 2nd line 18 - 70 03-05-2018 46 18
HOVON 74 ALL Closed n/a 2nd line 18 - 70 03-05-2018 2 8
HOVON 134 MF Open Level A - 18 - 70 y 18-10-2018 14 9
HOVON 151 DLBCL Open Level A, Level B, Level C-HIC, Level C-SCT 1st line 18 - 75 05-12-2018 n/a 3
HOVON 79 APL / PETHEMA LPA 2005 Closed Level B 1st line 18 - 75 03-05-2018 90 11
HOVON 68 CLL Closed n/a 1st line 18 - 75 03-05-2018 274 71
HOVON 52 AML Closed n/a 1st line 18 - 75 03-05-2018 n/a n/a
HOVON 84 NHL Closed n/a 1st line 18 - 80 03-05-2018 585 68
HOVON 58 ET Closed n/a 1st line 18 - 80 03-05-2018 7 9
HOVON 107 MOBILIZATION Closed Level A - 18-60 07-12-2018 38 4
HOVON 131 MM / IFM 2015-01 Closed n/a 1st line 18-65 03-05-2018 n/a n/a
HOVON 108 MM Closed Level A 2nd line 18-65 19-10-2018 30 7
HOVON 106 DOUBLE UCBT Closed n/a - 18-65 03-05-2018 41 5
HOVON 95 MM Closed Level D 1st line 18-65 03-05-2018 n/a 190
HOVON-associated EMN17 Perseus Trial Planned Level A - 18-70 19-09-2018 n/a n/a
HOVON 104 AL AMYLOIDOSIS Closed n/a 1st line 18-70 07-12-2018 57 18
HOVON 144 NHL Planned Level D 2nd line 18-70 en 71-85 09-11-2018 n/a n/a
HOVON 127 BL Open Level C-HIC 1st line 18-75 31-05-2018 40 22
HOVON 71 ALL Closed n/a 1st line 40 - 70 03-05-2018 60 21
HOVON 53 AML / OSHO Closed n/a 1st line 50 - 75 03-05-2018 59 10
HOVON 91 T-NHL (ACT-2) Closed n/a 1st line 61-80 03-05-2018 n/a n/a
HOVON 109 CLL Closed Limited site selection 1st line 65 years – 80 years, inclusive; 18 - 64 years, inclusive, with CIRS ≥7 09-11-2018 63 34
HOVON 41 AL Amyloidosis Closed n/a 1st line < 66 03-05-2018 70 13
HOVON 24 MM / OG 96-020 Closed n/a 1st line < 66 03-05-2018 n/a n/a
HOVON-associated MM and haplo Open n/a 3rd line < 66 yrs 23-05-2016 n/a n/a
HOVON 143 MM Open Level D 1st line > 18 04-12-2018 116 49
HOVON 64 ITP Closed n/a 1st line > 18 03-05-2018 151 35
HOVON 60 MDS / SAKK 33/99 Closed n/a 1st line > 18 19-08-2018 6 3
HOVON 39 NHL / EORTC 20981 Closed n/a 2nd line > 18 03-05-2018 77 32
HOVON 30 AML Closed n/a 1st line > 18 03-05-2018 80 19
HOVON 20 CML Closed n/a 1st line > 18 03-05-2018 n/a n/a
HOVON 900 DLBCL screening Open 1st line > 18 year 16-07-2018 1059 66
HOVON 81 AML Closed n/a 1st line > 60 03-05-2018 n/a n/a
HOVON 77 NHL Closed n/a 1st line > 60 03-05-2018 19 24
HOVON 43 AML Closed n/a 1st line > 60 19-10-2018 n/a n/a
HOVON 36 MM Closed n/a 1st line > 64 03-05-2018 69 49
HOVON 49 MM Closed n/a 1st line > 65 03-05-2018 344 64
HOVON 47 NHL Closed n/a 1st line > 65 03-05-2018 13 39
HOVON 25 NHL / OG 95-004 Closed n/a 1st line > 65 03-05-2018 n/a n/a
HOVON 120 NHL (ZEST) Closed n/a 2nd line > = 60 03-05-2018 n/a n/a
HOVON Pomalidomide project Open n/a 3rd line >18 17-11-2015 n/a n/a
HOVON-associated Innate allo-SCT Closed n/a - >18 19-11-2018 n/a n/a
HOVON 150 AML Planned Level C-HIC & C-SCT - >18 jaar 03-10-2018 n/a n/a
HOVON 136 NHL Open Level B 2nd line >18 years 03-10-2018 3 7
HOVON 129 PCL Open Level A 2nd line >18 yrs 13-09-2018 n/a 17
HOVON 153 NIVEAU Planned Level D 2nd line >65 19-02-2018 n/a n/a
HOVON-associated Acerta CL-007 Closed n/a - >65 OR >18 - 65 23-03-2018 n/a n/a
HOVON-associated TARGET study Planned Level A - >= 18 26-11-2018 n/a n/a
HOVON-associated Murano study Closed n/a 2nd line >= 18 31-08-2015 n/a n/a
HOVON-associated GLOW study Open Limited site selection 3rd line >= 18 10-12-2018 n/a n/a
HOVON 114 MM Open Limited site selection 2nd line >= 18 12-11-2018 n/a 33
HOVON 101 CLL/OMB112517 Closed n/a 2nd line >= 18 03-05-2018 n/a 19
HOVON 82 Sanquin Closed n/a 1st line >= 18 03-05-2018 295 8
HOVON 73 NHL / PRIMA Closed n/a 1st line >= 18 03-05-2018 18 14
HOVON 57 MM Closed n/a 1st line >= 18 03-05-2018 24 10
HOVON 48 NHL / NHLFIT Closed n/a 2nd line >= 18 03-05-2018 n/a n/a
HOVON-associated MEDI4736-NHL-001 Closed n/a 2nd line >= 18 18-01-2018 n/a n/a
HOVON 110 FL Open n/a 2nd line >= 18 years 16-11-2018 89 51
HOVON-associated PLMA25 NK-cell study Closed n/a - >= 55 29-09-2015 n/a n/a
HOVON 119 MCL Open Level D 1st line >= 60 17-10-2018 n/a 24
HOVON 97 AML Closed Level C-HIC 1st line >= 60 03-05-2018 116 25
HOVON 67 AML / SAKK Closed n/a 1st line >= 60 03-05-2018 6 9
HOVON 93 AML / EBMT Closed Level B 1st line >= 60 <= 75 03-05-2018 n/a 6
HOVON 61 NHL Closed n/a 1st line >= 65 03-05-2018 n/a 7
HOVON 46 NHL Closed n/a 1st line >= 65 03-05-2018 265 73
HOVON 137 NHL Planned Level D - >= 75 03-05-2018 n/a n/a
HOVON 123 MM Closed Level D 1st line >= 75 03-05-2018 240 57
HOVON-associated Transplant BRaVE Closed n/a - >=18 03-05-2018 n/a n/a
HOVON-associated SADAL trial (Protocol KCP-330-009) Open Level A 2nd line >=18 05-03-2018 n/a n/a
HOVON-associated GO27878 study (Cavalli study) Closed n/a - >=18 09-02-2017 n/a n/a
HOVON-associated CC-122 NHL-001 Closed n/a 2nd line >=18 03-12-2018 n/a n/a
HOVON-associated CARINA (Protocol 54767414LYM2001) Closed Limited site selection 3rd line >=18 07-12-2016 n/a n/a
HOVON-associated Anti-CD20 cGVHD study Closed n/a - >=18 09-12-2015 n/a n/a
HOVON-associated Acerta CL-006 Closed n/a 2nd line >=18 23-03-2018 n/a n/a
HOVON-associated ACE WM-001 Closed n/a - >=18 24-12-2015 n/a n/a
HOVON-associated ACE LY-004 Closed n/a - >=18 24-12-2015 n/a n/a
HOVON 141 CLL Open Level D 2nd line >=18 03-12-2018 214 47
HOVON 140 CLL Open Level D 1st line >=18 18-10-2018 n/a 37
HOVON 139 CLL (GIVE) Closed Level D 1st line >=18 13-11-2018 70 25
HOVON 98 / OMB110928 Closed n/a 2nd line >=18 03-05-2018 n/a n/a
HOVON 89 MDS Closed Level D 1st line >=18 30-11-2018 184 54
HOVON 86 MM Closed Level C-HIC & C-SCT 2nd line >=18 03-05-2018 81 25
HOVON 85 NHL Closed n/a 2nd line >=18 03-05-2018 61 27
HOVON-associated MK-3475-087 Closed n/a 2nd line >=18 02-05-2016 n/a n/a
HOVON-associated GO29365 Closed Limited site selection 1st line >=18 14-10-2016 n/a n/a
HOVON 156 AML Planned Level C-HIC & C-SCT - >=18 y 02-08-2018 n/a n/a
HOVON 124 WM Open Limited site selection 2nd line >=18 y 08-06-2018 57 16
HOVON 147 SMM Open Level C-HIC 2nd line >=18 years 04-12-2018 n/a 1
HOVON 117 ALL On hold n/a 1st line >=55 03-05-2018 n/a 1
HOVON 55 MCL Closed n/a 1st line >=65 or 60-65 (see inclusion criteria) 03-05-2018 95 30
HOVON 135 AML / SAKK Closed Limited site selection 1st line >=66 18-06-2018 147 34
HOVON 103 AML Open Level C-HIC 1st line >=66 19-04-2018 677 30
HOVON 113 MSC Open Level A, Level B 2nd line Any age 03-05-2018 34 8
HOVON 112 MSC On hold Level A 1st line Any age 03-05-2018 39 2
HOVON 152 DLBCL Open Level D 1st line ≥ 18 15-11-2018 4 1
HOVON 130 NHL Closed Level D 1st line ≥ 18 20-09-2018 83 23
HOVON 121 CLLM1/GCLLSG Closed Level D - ≥ 18 03-05-2018 n/a 4
HOVON 142 CML -SUSTRENIM-CML1415 Planned Level A, Level B, Level C-HIC & C-SCT 1st line ≥18 12-12-2018 n/a n/a
HOVON 87 MM Closed Level D 1st line prev. untreated > 65 or <=65 when inelig. for HDT & PCST 14-11-2018 643 96